Phase II study of D.651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis-Reference-Cited by-同舟云学术

Phase II study of D.651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis

Author:

Levy D.A.,Bohbot J.M.,Catalan F.,Normier G.,Pinel A.M.,Dussourd d'Hinterland L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference19 articles.

1. Immunogenic activity of a ribosomal fraction obtained from Mycobacterium tuberculosis;Youmans;J. Bacteriol.,1965

2. Microbial ribosomal vaccines;Gregory;Rev. Infect. Dis.,1986

3. Preparation and effect of different adjuvants on the immunogenic activity of mycobacterial ribosomal fraction;Youmans;J. Bacteriol.,1967

4. Ribosomal vaccines: Preparation of subcellular fractions;Dussourd d'Hinterland;Arzneim. Forsch.,1980

5. Prévention de l'infection respiratoire bactérienne par une association de ribosomes bactériens et d'adjuvant membranaire;Michel,1977

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Current Antifungal Drugs;Current Trends in the Identification and Development of Antimicrobial Agents;2023-03-07